(Q35607320)

9 August 2017

10 references

23 March 2019

24 March 2019

20 June 2019

17 June 2019

25 June 2019

19 October 2019

1 July 2020

22 January 2021

26 January 2021

25 October 2022

The pathophysiology of HIV-/HAART-related metabolic syndrome leading to cardiovascular disorders: the emerging role of adipokines (English)

1 reference

human immunodeficiency virus infectious disease

9 August 2017

main subject

cardiovascular disease

7 references

23 March 2019

24 March 2019

20 June 2019

17 June 2019

25 June 2019

19 October 2019

1 July 2020

7 references

23 March 2019

24 March 2019

20 June 2019

17 June 2019

25 June 2019

19 October 2019

1 July 2020

7 references

23 March 2019

24 March 2019

20 June 2019

17 June 2019

25 June 2019

19 October 2019

1 July 2020

Retroviridae infectious disease

1 reference

highly active antiretroviral therapy

19 October 2019

2 references

22 January 2021

26 January 2021

John Palios

1

1 reference

9 August 2017

Nikolaos P E Kadoglou

series ordinal

2

1 reference

9 August 2017

Stylianos Lampropoulos

series ordinal

3

1 reference

9 August 2017

language of work or name

1 reference

8 December 2011

11 references

Experimental Diabetes Research

9 August 2017

23 March 2019

24 March 2019

20 June 2019

17 June 2019

25 June 2019

19 October 2019

1 July 2020

22 January 2021

26 January 2021

25 October 2022

11 references

9 August 2017

23 March 2019

24 March 2019

20 June 2019

17 June 2019

25 June 2019

19 October 2019

1 July 2020

22 January 2021

26 January 2021

25 October 2022

2012

1 reference

9 August 2017

page(s)

103063

1 reference

Creative Commons Attribution 3.0 Unported

9 August 2017

copyright license

10 references

23 March 2019

24 March 2019

20 June 2019

17 June 2019

25 June 2019

19 October 2019

1 July 2020

22 January 2021

26 January 2021

on focus list of Wikimedia project

25 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Resistin: functional roles and therapeutic considerations for cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

The role of adiponectin in metabolic and vascular disease: a review.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Inflammation, adiponectin, obesity and cardiovascular risk

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Adipocytokines, cardiovascular pathophysiology and myocardial protection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

The HIV-1/HAART associated metabolic syndrome - novel adipokines, molecular associations and therapeutic implications.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Rationale for leptin-replacement therapy for severe lipodystrophy.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Resistin: regulation of food intake, glucose homeostasis and lipid metabolism

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Characteristics associated with fasting appetite hormones (obestatin, ghrelin, and leptin).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Genetic analysis implicates resistin in HIV lipodystrophy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Expanding role for the apelin/APJ system in physiopathology.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

How HIV protease inhibitors promote atherosclerotic lesion formation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Adipokines: inflammation and the pleiotropic role of white adipose tissue

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Expression and coreceptor function of APJ for primate immunodeficiency viruses

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Combination antiretroviral therapy and the risk of myocardial infarction

12 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

HIV-positive patients treated with protease inhibitors have vascular changes resembling those observed in atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Determinants of endothelial function in human immunodeficiency virus infection: a complex interplay among therapy, disease, and host factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

HIV lipodystrophy: prevalence, severity and correlates of risk in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

The HIV protease inhibitor saquinavir impairs lipid metabolism and glucose transport in cultured adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infect

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Association of highly active antiretroviral therapy with increased arterial stiffness in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Disruption of peripheral leptin signaling in mice results in hyperleptinemia without associated metabolic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Serum leptin concentrations and fat redistribution in HIV-1-infected children on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Age and sex modulate metabolic and cardiovascular risk markers of patients after 1 year of highly active antiretroviral therapy (HAART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Cystatin C, adipokines and cardiovascular risk in HIV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

In treatment-naïve and antiretroviral-treated subjects with HIV, reduced plasma adiponectin is associated with a reduced fractional clearance rate of VLDL, IDL and LDL apolipoprotein B-100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Apelin peptides block the entry of human immunodeficiency virus (HIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Vaspin serum concentrations in patients with carotid stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Alterations in lipid kinetics in men with HIV-dyslipidemia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3235775

Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy

25 September 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

Vaspin: a novel serpin with insulin-sensitizing effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F103063

The Role of Immunity and Inflammation in the Progression of Atherosclerosis in Patients With HIV Infection

21 January 2018

1 reference

12 December 2020

Adipokine resistin is a key player to modulate monocytes, endothelial cells, and smooth muscle cells, leading to progression of atherosclerosis in rabbit carotid artery

1 reference

12 December 2020

Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects

1 reference

12 December 2020

Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study

1 reference

12 December 2020

Lipodystrophy and Insulin Resistance in Combination Antiretroviral Treated HIV-1–Infected Patients: Implication of Resistin

1 reference

12 December 2020

Adiponectin and leptin levels in Chinese patients with HIV-related lipodystrophy: a 30-month prospective study

1 reference

12 December 2020

HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction

1 reference

12 December 2020

Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study

1 reference

12 December 2020

Apelin: a novel marker for the patients with first ST-elevation myocardial infarction

1 reference

12 December 2020

Regulation of adiponectin in adipocytes upon exposure to HIV-1

1 reference

12 December 2020

Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease--KOZANI STUDY

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/103063

1 reference

9 August 2017

1 reference

9 August 2017

1 reference